FELICE, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.738
AS - Asia 1.538
EU - Europa 997
AF - Africa 590
SA - Sud America 381
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 25
Totale 5.325
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.479
SG - Singapore 435
HK - Hong Kong 342
BR - Brasile 212
CN - Cina 187
IT - Italia 123
DE - Germania 89
PL - Polonia 81
FI - Finlandia 74
RU - Federazione Russa 55
VN - Vietnam 54
AT - Austria 36
AR - Argentina 33
GB - Regno Unito 32
TR - Turchia 32
FR - Francia 29
MK - Macedonia 29
IQ - Iraq 27
SE - Svezia 26
NL - Olanda 25
IL - Israele 23
MR - Mauritania 22
MX - Messico 22
ES - Italia 21
IE - Irlanda 21
MN - Mongolia 21
NO - Norvegia 21
TN - Tunisia 21
TT - Trinidad e Tobago 21
BA - Bosnia-Erzegovina 20
DZ - Algeria 20
GH - Ghana 20
AL - Albania 19
AZ - Azerbaigian 19
BB - Barbados 19
CV - Capo Verde 19
DO - Repubblica Dominicana 19
GN - Guinea 19
UY - Uruguay 19
ZA - Sudafrica 19
BW - Botswana 18
CG - Congo 18
EC - Ecuador 18
ID - Indonesia 18
JO - Giordania 18
JP - Giappone 18
KG - Kirghizistan 18
LA - Repubblica Popolare Democratica del Laos 18
AO - Angola 17
BF - Burkina Faso 17
CI - Costa d'Avorio 17
ET - Etiopia 17
HR - Croazia 17
HT - Haiti 17
LU - Lussemburgo 17
MA - Marocco 17
PT - Portogallo 17
UA - Ucraina 17
BG - Bulgaria 16
BZ - Belize 16
CD - Congo 16
CO - Colombia 16
DK - Danimarca 16
EG - Egitto 16
GT - Guatemala 16
IS - Islanda 16
MU - Mauritius 16
PE - Perù 16
PY - Paraguay 16
RO - Romania 16
UG - Uganda 16
YT - Mayotte 16
DJ - Gibuti 15
GF - Guiana Francese 15
HN - Honduras 15
IN - India 15
KE - Kenya 15
KR - Corea 15
LV - Lettonia 15
MD - Moldavia 15
MY - Malesia 15
NC - Nuova Caledonia 15
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
AF - Afghanistan, Repubblica islamica di 14
BE - Belgio 14
BO - Bolivia 14
CR - Costa Rica 14
GA - Gabon 14
GE - Georgia 14
GP - Guadalupe 14
LB - Libano 14
NP - Nepal 14
PH - Filippine 14
PS - Palestinian Territory 14
TW - Taiwan 14
TZ - Tanzania 14
VE - Venezuela 14
XK - ???statistics.table.value.countryCode.XK??? 14
AM - Armenia 13
Totale 4.745
Salva come PNG Salva come JPEG
Città #
Hong Kong 328
Singapore 274
Fairfield 146
Ashburn 133
Chandler 129
Santa Clara 108
Beijing 100
Boardman 71
San Diego 65
Bytom 63
Medford 60
Princeton 60
Roxbury 53
Munich 43
Helsinki 40
Padova 39
Houston 37
Cambridge 36
Woodbridge 32
Seattle 30
Ho Chi Minh City 25
Wilmington 23
Nouakchott 21
Los Angeles 20
Ulan Bator 20
Dublin 19
Vienna 19
Baku 18
Conakry 18
São Paulo 18
Abidjan 17
Amman 17
Montevideo 17
Praia 17
Accra 16
Ann Arbor 16
Bridgetown 16
Chicago 16
Istanbul 16
Kampala 16
Lappeenranta 16
Vientiane 16
Bishkek 15
Skopje 15
Djibouti 14
Libreville 14
Luanda 14
Noumea 14
Sofia 14
Cayenne 13
Hefei 13
Lima 13
Managua 13
New York 13
Riga 13
Tel Aviv 13
Turku 13
Baghdad 12
Dar es Salaam 12
Gaborone 12
Harare 12
Kinshasa 12
Niamey 12
Tirana 12
Belo Horizonte 11
Maputo 11
Nuremberg 11
Ouagadougou 11
Phnom Penh 11
Podgorica 11
Port-au-Prince 11
Reykjavik 11
Tbilisi 11
Yerevan 11
Addis Ababa 10
Cotonou 10
Dakar 10
Hanoi 10
Minsk 10
Nairobi 10
Pristina 10
Santo Domingo 10
Tallinn 10
Antananarivo 9
Bamako 9
Belize City 9
Chisinau 9
Dili 9
Guatemala City 9
Kigali 9
Luxembourg 9
Nassau 9
Port of Spain 9
Salt Lake City 9
San José 9
Tashkent 9
Tegucigalpa 9
Willemstad 9
Andorra la Vella 8
Belgrade 8
Totale 2.883
Salva come PNG Salva come JPEG
Nome #
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives 142
Impact of COVID-19 Outbreak on Healthcare Workers in Italy: Results from a National E-Survey 137
Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta‐Analysis 134
Coronavirus disease 2019 in Italy: the Veneto Model 123
The emerging role of nutraceuticals in cardiovascular calcification: Evidence from preclinical and clinical studies 122
Comparison between dexamethasone and methylprednisolone therapy in patients with COVID-19 pneumonia admitted to non-intensive medical units 122
Changes in hospital admissions and complications of acute appendicitis during the {COVID}-19 pandemic: A systematic review and meta-analysis 115
Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study 107
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 106
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 96
Anoplasty for anatomical anal stenosis: systematic review of complications and recurrences 95
Shaping Rare Granulomatous Diseases in the Lab: How New Models Are Changing the Game 94
null 90
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 89
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: An unreported association 88
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 87
Anal Fistula Human Amniotic Membrane Endosealing (F-HAME): A Proof of Concept Study 86
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study 84
Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome 84
NETosis in Acute Thrombotic Disorders 78
Biological therapies for inflammatory bowel disease: Controversies and future options 75
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022 71
Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications 71
AID in aging and autoimmune diseases 71
Vascular involvement in inflammatory bowel disease: Pathogenesis and clinical aspects 70
A case of hereditary hemorrhagic telangiectasia associated with crohn's disease successfully treated with infliximab 70
Intima-media thickness in inflammatory bowel disease patients: A still open question [9] 68
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 68
GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis 67
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review 66
Inducing remission of ulcerative colitis: Are clinicians better equipped than ever? 66
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future 66
The Importance of Endoscopy with Biopsy: Real-World Evidence of Gastrointestinal Involvement in Primary Immunodeficiency in Two Main Northern Italian Centres 65
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study 65
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 64
Achievement of sustained deep remission with Adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 63
Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: An observational multicentre study 63
Use of infliximab in particular clinical settings: Management based on current evidence 62
Non-biological therapy in inflammatory bowel disease-old and new evidence 62
Ileal Crohn's disease: CEUS determination of activity 62
Management of perianal fistulas in Cohn's disease: An up-to-date review 62
Total Abdominal Colectomy for Refractory Ulcerative Colitis. Surgical Treatment in Evolution 61
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients 61
FOXP3+ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNF α agents 61
Therapeutic Role of Appendectomy in Ulcerative Colitis: A Tangible Perspective? 61
Chest radiography findings of COVID-19 pneumonia: a specific pattern for a confident differential diagnosis 60
Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment 60
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants 60
Infliximab in steroid-dependent ulcerative colitis: Effectiveness and predictors of clinical and endoscopic remission 60
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 59
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study 59
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 59
Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review 59
The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients 59
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 58
IBD: Infliximab dose optimization in IBD - Proactive or reactive? 57
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis 57
Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients 57
Etrolizumab in moderate-to-severe ulcerative colitis 57
TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine 57
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis 57
Infliximab: A review of its use in the treatment of inflammatory Bowel disease 55
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 55
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 54
Review article: Selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases 53
Reply to Dr. Kotze's and Dr. Yamamoto's letter 53
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts 53
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 52
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 52
New biological agents for the treatment of the "high risk" IBD patients 50
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 50
The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases 47
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 45
Natalizumab in Crohn's disease: Past and future areas of applicability 43
New therapeutic approach in inflammatory bowel disease 38
EPIGENETIC AND METABOLIC REPROGRAMMING OF FIBROBLASTS IN CROHN'S DISEASE STRICTURES REVEALS HISTONE DEACETYLASES AS THERAPEUTIC TARGETS 29
Antibodies against integrin αvβ6 have high diagnostic accuracy for ulcerative colitis 25
Non-infectious pulmonary and gastrointestinal manifestations in primary antibody deficiencies: lessons for the clinic 11
null 7
Totale 5.427
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.389
article - articoli 23.389
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 1 10 10 7 5 8 9 1 17
2021/2022565 22 17 45 2 3 4 24 42 10 3 261 132
2022/2023328 99 6 4 21 48 41 2 42 24 7 30 4
2023/2024310 16 19 45 30 20 39 34 8 16 3 44 36
2024/20251.417 1 54 20 26 209 40 69 127 167 72 296 336
2025/20262.696 243 322 1.300 831 0 0 0 0 0 0 0 0
Totale 5.427